Skip to main content
Clinical Trials/NCT01914445
NCT01914445UnknownNot Applicable

Chromoendoscopy of the Colon After Oral Administration of Indigo Carmine

Hillel Yaffe Medical Center1 site in 1 country10 target enrollmentStarted: August 2013Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Enrollment
10
Locations
1
Primary Endpoint
Efficacy of Indigo Carmine during oral administration

Study Overview

Brief Summary

The purpose of this study is to examine whether oral administration of Indigo Carmine together with Polyethylene Glycol (PEG), the usual colon preparatory solution, can be used instead of staining during the examination itself.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients suffering from Inflammatory Bowel Disease
  • Patients under surveillance for Disease-Associated Lesions and Masses (DALM)

Exclusion Criteria

  • All others

Arms & Interventions

Indigo Carmine

Experimental

Indigo Carmine (2 mg per kilo) and 2nd half of PEG dose will be orally administered to patients prior to colonoscopy.

Intervention: Indigo Carmine (Drug)

Outcomes

Primary Outcomes

Efficacy of Indigo Carmine during oral administration

Time Frame: One hour

The efficacy of Indigo Carmine in staining tissues to better characterize, delineate, and highlight the gastrointestinal mucosa will be determined during the colonoscopic examination. Biopsies will be taken from suspicious lesions.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other Gov
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials